Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.
Amato L, De Rosa C, De Rosa V, Heydari Sheikhhossein H, Ariano A, Franco P, Nele V, Capaldo S, Di Guida G, Sepe F, Di Liello A, De Rosa G, Tuccillo C, Gambardella A, Ciardiello F, Morgillo F, Tirino V, Della Corte CM, Iommelli F, Vicidomini G. Amato L, et al. Among authors: de rosa v. Cancers (Basel). 2024 Sep 14;16(18):3151. doi: 10.3390/cancers16183151. Cancers (Basel). 2024. PMID: 39335123 Free PMC article.
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S. Iommelli F, et al. Among authors: de rosa v. Clin Cancer Res. 2014 Sep 15;20(18):4806-15. doi: 10.1158/1078-0432.CCR-14-0264. Epub 2014 Jul 22. Clin Cancer Res. 2014. PMID: 25052479
Preclinical imaging in oncology: advances and perspectives.
Iommelli F, DE Rosa V, Terlizzi C, Del Vecchio S. Iommelli F, et al. Among authors: de rosa v. Q J Nucl Med Mol Imaging. 2017 Mar;61(1):33-47. doi: 10.23736/S1824-4785.16.02949-6. Epub 2016 Nov 18. Q J Nucl Med Mol Imaging. 2017. PMID: 27858408 Free article. Review.
Preclinical Imaging in Targeted Cancer Therapies.
Iommelli F, De Rosa V, Terlizzi C, Fonti R, Del Vecchio S. Iommelli F, et al. Among authors: de rosa v. Semin Nucl Med. 2019 Sep;49(5):369-381. doi: 10.1053/j.semnuclmed.2019.06.003. Epub 2019 Jun 19. Semin Nucl Med. 2019. PMID: 31470932 Review.
Preclinical imaging for targeting cancer immune evasion.
Terlizzi C, De Rosa V, Iommelli F, Altobelli GG, Fonti R, Del Vecchio S. Terlizzi C, et al. Among authors: de rosa v. Q J Nucl Med Mol Imaging. 2020 Jun;64(2):186-193. doi: 10.23736/S1824-4785.20.03254-9. Epub 2020 Apr 14. Q J Nucl Med Mol Imaging. 2020. PMID: 32286769 Review.
240 results